Continental Beverage & Nutrition Announces Appointment of Dr. Leonard Makowka to Company's Board of Advisors

GARDEN CITY, N.Y., Oct 20, 2004 (PRIMEZONE via COMTEX) -- Continental Beverage & Nutrition, Inc. (COBN) today announced that it has engaged Dr. Leonard Makowka to become a member of its Board of Advisors. Dr. Makowka is a world leading authority in hepatic science (study relating to the liver) who trained under Dr. Thomas Starzl, the pioneer of liver transplantation. Dr. Makowka became the Chairman of the Department of Surgery and Director of Transplantation Services at Cedars-Sinai Medical Center in Los Angeles, California, and the Founder/Executive Director of the Comprehensive Liver Disease/Treatment Center at St. Vincent Medical Center in Los Angeles, California.

Dr. Makowka has been published over 400 times about both clinical and basic scientific research, has lectured worldwide as one of the world's leading authorities in his field, and has performed hundreds of hepatobiliary and liver transplant procedures. He has since retired from the active practice of medicine to pursue investment strategies and business development, as well as lending his expertise in an advisory capacity in healthcare, life sciences, and other industry sectors related to quality of life issues, including such companies as Hollis Eden Pharmaceuticals (HEPH), Kinemed, Inc., Desert Health Products, Inc. (DHPI), Unigen Pharmaceuticals, Universal Detection Systems (UDTT), and Hythiam (HTM).

"We are thrilled to have Dr. Makowka join our Board of Advisors," said CB&N President/CEO, David Sackler. "His extensive and unique medical and business background, and awareness of quality of life issues, provides us a breadth of experience and knowledge that can be invaluable to the company in both a product development and industry direction capacity. We look forward to working with him."

About Continental Beverage & Nutrition, Inc.:

Continental Beverage & Nutrition, Inc. develops, produces, and markets bottled water and nutritionally enhanced beverage products for distribution and sale throughout North America.

This news release contains forward-looking statements. Forward-looking statements include statements concerning plans, objectives, goals, strategies, future events or performance and underlying assumptions and other statements, which are other than statements of historical facts. These statements are subject to uncertainties and risks including, but not limited to, product and service demand and acceptance, changes in technology, economic conditions, the impact of competition and pricing, and government regulation and approvals. All such forward-looking statements, whether written or oral, and whether made by, or on behalf of Continental Beverage & Nutrition, Inc., are expressly qualified by these cautionary statements and any other cautionary statements which may accompany the forward-looking statements. In addition, Continental Beverage & Nutrition, Inc. disclaims any obligation to update any forward-looking statements to reflect events or circumstances after the date hereof.

Hide comments


  • Allowed HTML tags: <em> <strong> <blockquote> <br> <p>

Plain text

  • No HTML tags allowed.
  • Web page addresses and e-mail addresses turn into links automatically.
  • Lines and paragraphs break automatically.